Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Sales | 2,839,300 | 2,777,900 | 2,591,600 | 2,555,000 | 2,640,650 |
| Cost of Goods | 331,900 | 310,000 | 286,100 | 312,400 | 297,229 |
| Gross Profit | 2,507,399 | 2,467,900 | 2,305,500 | 2,242,600 | 2,343,422 |
| Operating Expenses | 1,340,300 | 1,096,000 | 1,072,500 | 1,125,000 | 1,183,802 |
| Operating Income | 1,168,200 | 1,371,800 | 1,233,100 | 1,117,900 | 1,159,749 |
| Other Income | -82,400 | -22,200 | -15,800 | -15,800 | -8,938 |
| Pre-tax Income | 1,085,800 | 1,349,600 | 1,217,300 | 1,102,100 | 1,150,811 |
| Income Tax | 257,100 | 330,100 | 292,500 | 281,900 | 268,191 |
| Net Income Continuous | 828,700 | 1,019,500 | 924,800 | 820,200 | 882,620 |
| Minority Interests | -2,800 | 53,900 | -2,500 | -2,400 | -860 |
| Net Income | $831,500 | $965,600 | $927,300 | $822,600 | $883,480 |
| EPS Basic Total Ops | 3.78 | 4.16 | 3.94 | 3.50 | 3.74 |
| EPS Basic Continuous Ops | 3.76 | 4.39 | 3.93 | 3.49 | 3.74 |
| EPS Diluted Total Ops | 3.77 | 4.15 | 3.93 | 3.49 | 3.72 |
| EPS Diluted Continuous Ops | 3.75 | 4.38 | 3.92 | 3.48 | 3.73 |
| EBITDA(a) | $1,324,300 | $1,523,500 | $1,377,700 | $1,265,900 | $1,317,441 |